Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.39 USD | +3.73% | -18.71% | +9.45% |
Chart calendar Inhibikase Therapeutics, Inc.
Upcoming events on Inhibikase Therapeutics, Inc.
Past events on Inhibikase Therapeutics, Inc.
04/04/2024 | U.S. Food and Drug Administration Pre IND Meeting |
28/03/2024 12:00 | Q4 2023 Earnings Call |
27/03/2024 20:15 | Q4 2023 Earnings Release |
09/03/2024 18:25 | AD/PD Alzheimers and Parkinsons Diseases Conference |
15/11/2023 13:00 | Q3 2023 Earnings Call |
14/11/2023 21:30 | Q3 2023 Earnings Release |
11/09/2023 | H.C. Wainwright Global Investment Conference |
29/08/2023 12:45 | Parkinson Disease and Movement Disorders International Congress - Abstract No: 155 |
28/08/2023 12:45 | Parkinson Disease and Movement Disorders International Congress - Abstract No: 1444 |
15/08/2023 13:00 | Q2 2023 Earnings Call |
14/08/2023 21:20 | Q2 2023 Earnings Release |
23/06/2023 14:30 | Annual General Meeting |
06/06/2023 20:00 | LD Micro Invitational Conference |
16/05/2023 13:00 | Q1 2023 Earnings Call |
15/05/2023 13:30 | Q1 2023 Earnings Release |
11/05/2023 18:45 | Sidoti Micro-Cap Virtual Conference |
04/05/2023 | Annual General Meeting |
26/04/2023 21:00 | Planet MicroCap Showcase |
25/04/2023 | American Academy of Neurology Meeting |
03/04/2023 13:00 | Q4 2022 Earnings Call |
Annual results
Fiscal Period | December | 2020 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,70 | 0,00 | 0,26 0,26 -0.19% | 0,00 |
EBITDA | Released Forecast Spread | 0,00 | 0,00 | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | 0,00 | 0,00 | -20,1 -20,6 2.51% | -23,8 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | 0,00 | -19,0 -19,7 3.64% | -23,8 |
Net income Million USD | Released Forecast Spread | 0,00 | -18,1 | -19,0 -19,7 3.42% | -23,8 |
EPS USD | Released Forecast Spread | -2,10 | -4,32 | -3,57 -2,76 -29.58% | -1,78 |
Announcement Date | 31/03/21 | 31/03/23 | 27/03/24 | - |
Quarterly results
Fiscal Period | December | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,06 0,00 - | 0,12 0,00 - | 0,08 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -4,71 -4,46 -5.76% | -6,20 -5,04 -23.16% | -4,77 -6,36 25.01% | -4,40 -4,92 10.51% | -5,00 | -5,06 | -5,16 | -5,27 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -4,18 -4,90 14.68% | |||||||
Net income Million USD | Released Forecast Spread | -4,48 -4,41 -1.56% | -5,78 -4,77 -21.11% | -4,60 -6,01 23.59% | -4,18 -4,85 13.88% | -4,89 | -5,00 | -5,03 | -5,17 |
EPS USD | Released Forecast Spread | -0,96 -0,90 -6.67% | -1,11 -0,92 -20.65% | -0,86 -1,12 23.21% | -0,64 -0,85 24.71% | -0,79 | -0,37 | -0,37 | -0,38 |
Announcement Date | 15/05/23 | 14/08/23 | 14/11/23 | 27/03/24 | - | - | - | - |
Past sector events for Inhibikase Therapeutics, Inc.
02/05/2024 21:10 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
02/05/2024 21:05 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
02/05/2024 21:05 | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release |
02/05/2024 21:01 | GALAPAGOS NV: Q1 2024 Earnings Release |
02/05/2024 13:00 | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
02/05/2024 12:05 | SHATTUCK LABS, INC.: Q1 2024 Earnings Release |
02/05/2024 12:00 | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
02/05/2024 12:00 | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
02/05/2024 12:00 | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
02/05/2024 11:30 | MODERNA, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IKT Stock
- Calendar Inhibikase Therapeutics, Inc.